Prostate Cancer - Results from #22300

Dose-adapted salvage radiotherapy after radical prostatectomy based on an erMRI target definition model: Toxicity analysis - Abstract October 15, 2013

Comparative study of the oncologic results of the radical prostatectomy versus external beam radiotherapy (75.6Gy) combined with concomitant hormonotherapy for prostate cancer at intermediate risk of D'Amico - Abstract October 15, 2013

MR-guided biopsy of the prostate: Comparison of diagnostic specimen quality with 18G and 16G biopsy needles - Abstract October 15, 2013

Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality - Abstract October 15, 2013

Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: The value of the pattern of surveillance biopsies - Abstract October 15, 2013

Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnife - Abstract October 15, 2013

Influence of obesity on localized prostate cancer patients treated with radical prostatectomy - Abstract October 15, 2013

Variants at IRX4 as prostate cancer expression quantitative trait loci - Abstract October 12, 2013

Prediction of immune surveillance responsive metastatic prostate cancer in pelvic lymph node and emergence of surveillance unresponsive/resistant metastatic cells - Abstract October 12, 2013

Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer - Abstract October 12, 2013

TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: Determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer - Abstract October 11, 2013

Improved wait time intervals for prostate cancer patients in a multidisciplinary rapid diagnostic unit compared to a community-based referral pattern - Abstract October 11, 2013

Comprehensive assessment and network analysis of the emerging genetic susceptibility landscape of prostate cancer - Abstract October 11, 2013

Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: The ZABTON-PC (Zoledronic Acid/Androgen Blockade Trial on Prostate Cancer) study - Abstract October 11, 2013

Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapy - Abstract October 11, 2013

Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer - Abstract October 11, 2013

Pelvic floor musculature and bladder neck changes before and after continence recovery after radical prostatectomy in pelvic MRI - Abstract October 11, 2013

Image-guided radiotherapy with implanted markers and kilovoltage imaging and 6-dimensional position corrections for intrafractional motion of the prostate - Abstract October 11, 2013

Intrusive thoughts and quality of life among men with prostate cancer before and three months after surgery - Abstract October 11, 2013

The validity of the distress thermometer in prostate cancer populations - Abstract October 11, 2013

Page 1116 of 1447